" class="no-js "lang="en-US"> Maciej Gamrot - Medtech Alert
Wednesday, September 03, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Maciej Gamrot

Maciej Gamrot

About Maciej Gamrot

CFO focused on improving efficiency and experienced in change implementation in Polish and international companies, public, private or VC/PE controlled.
Restructures, builds and manages teams, gets financing done, leads projects, implemented ERP.
Experienced in computer animation, tech start-up, TMT (media, internet, tech.), production (building materials, transportation), BIG 4.

Related Story

Artificial Intelligence

 Medicalgorithmics Secures FDA Approval for DeepRhytmAI Technology | Pharmtech Focus

Medicalgorithmics Secures FDA Approval for DeepRhytmAI Technology

August 11 2022

It is a cloud-based Artificial Intelligence algorithm that classifies ECG signals. Without excessive human involvement, […]